Eli Lilly & Co. (LLY) Tops Q1 EPS by 21c, Raises FY EPS Guidance

Go back to Eli Lilly & Co. (LLY) Tops Q1 EPS by 21c, Raises FY EPS Guidance

Eli Lilly (LLY) PT Raised to $82 at Credit Suisse

April 25, 2018 8:59 AM EDT

Credit Suisse raised its price target on Eli Lilly (NYSE: LLY) to $82.00 (from $80.00) while maintaining a Underperform rating.

... More

Eli Lilly (LLY) PT Lowered to $78 at BMO Capital

April 25, 2018 7:13 AM EDT

BMO Capital lowered its price target on Eli Lilly (NYSE: LLY) to $78.00 (from $79.00) while maintaining a Market Perform rating.

Analyst Alex Arfaei commented, "The revenue and EPS beat in 1Q18 looked impressive, but since it was driven by the mature... More

Eli Lilly (LLY) PT Maintained at $95 at Cowen on 1Q18 Report; 'Top & Bottom Line Beat... FY18 Guidance Raised'

April 24, 2018 11:50 AM EDT

Cowen maintained its price target on Eli Lilly (NYSE: LLY) at $95.00 while maintaining a Outperform rating, following the company's first quarter earnings report.

Analyst Steve Scala notes an upbeat outlook on the shares, as LLY reported first quarter sales and earnings per share results above... More